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Available online 1 September 2009The serotonin system densely innervates the brain and is implicated in psychopathological
processes. Here we studied the effect of serotonin and serotonin pharmacological
compounds on the outgrowth of serotonergic projections using organotypic slice co-
cultures of hippocampus and dorsal raphe nuclei. Immunocytochemical analysis showed
that several serotonergic neurites had grown into the target slice within 7 days in culture,
after which the neurite density stabilized. These projections expressed the serotonin-
synthesizing enzyme Tryptophan hydroxylase and the serotonin transporter and contained
several serotonin-positive varicosities that also accumulated presynaptic markers. Chronic
application of a 5-HT2 agonist reduced the serotonergic neurite density, without effects on
survival of serotonergic neurons. In contrast, application of a 5-HT1A agonist or the
serotonin transporter inhibitor fluoxetine did not affect serotonergic neurite density. We
conclude that serotonergic connectivity was reproduced in vitro and that the serotonin
neurite density is inhibited by chronic activation of the 5-HT2 receptor.






The serotonin (5-hydroxytryptamine (5-HT)) system has its
cell bodies clustered in the midbrain raphe nuclei and sends
abundant projections to virtually every brain area (Hornung,
2003; Rubenstein, 1998). The 5-HT system influences a wide






s Neuroscience and Cent
er B.V. All rights reservedrhythm, feeding, sexual behavior and nociception (Jacobs
and Azmitia, 1992). Moreover, the 5-HT system is implicated in
several psychopathological processes, such as anxiety, ag-
gression, obsessive–compulsive disorder and depression
(Castren, 2005).
During brain development, the 5-HT neurons are one of the
first groups of cells expressing a specific neurotransmitterpylamino)tetraline; DIV, days in vitro; dGBSS, dissection Gey's
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shows that alterations in brain 5-HT levels during develop-
ment could result in alterations in brain development and
behavioral alterations. 5-HT reuptake transporter (SERT)
knockout mice have an increase in extraneuronal 5-HT
(Bengel et al., 1998; Mathews et al., 2004). They exhibit
behavioral alterations, reduced number of 5-HT neurons in
the dorsal raphe nuclei (DRN) and reduced firing of the 5-HT
neurons in the DRN (Lira et al., 2003). These behavioral
alterations observed in SERT knockout mice can be mimicked
by application of the SERT inhibitor fluoxetine during devel-
opment between postnatal days 4 and 21 (Ansorge et al., 2004).
In contrast to reduction in brain 5-HT content after dis-
ruption of the SERT gene, there is a significant increase in brain
5-HT levels after inactivation of the monoamine oxidase A
(MAOA) gene (Cases et al., 1996). The chronic elevation of 5-HT
levels during brain development results in lack of barrels in the
barrel cortex (Cases et al., 1996). These data suggest that either
reductions in brain 5-HT levels or excess 5-HT levels during a
critical period in the development of the brain can lead to
abnormalities in brain development and behavioral altera-
tions. In vitro experiments have shown that 5-HT can inhibit
the outgrowth of neurites or even cause growth cone collapse
on 5-HT neurons (Haydon et al., 1984; Koert et al., 2001).
Whether alterations in brain 5-HT levels during development
of the brain result in alterations in 5-HT outgrowth, branching
or connectivity or whether the behavioral alterations observed
are a result of alterations in the 5-HT outgrowth and
connectivity is currently unknown. Organotypic slice cultures
of theDRNand a target slice could be a valuable reducedmodel
system to study 5-HT outgrowth in vitro.
Therefore, the aim of this study was to investigate whether
organotypic slice co-cultures of DRN and hippocampus, a
method that has previously been characterized, can be used to
study 5-HT outgrowth and the effect of pharmacological
manipulations in vitro (Guthrie et al., 2005; Papp et al., 1995).
We show that within 7 days of culturing several 5-HT neurites
have grown into the hippocampal slice. Using these slice co-
cultures, we studied whether chronic application of 5-HT
pharmacological compounds affects the outgrowth of 5-HT
neurites from the DRN. To this end, we used a 5-HT1A receptor
agonist, a 5-HT2 receptor agonist and the SERT inhibitor
fluoxetine since it has been shown before, also on non-5-HT
cells, that (chronic) activation of a 5-HT1A or 5-HT2 receptor or
blockade of the SERT can affect (5-HT) outgrowth or synapto-
genesis (Fricker et al., 2005; Kondoh et al., 2004; Wilson et al.,
1998; Zhou et al., 2006). We show here that chronic application
of a 5-HT2 agonist results in a reduction in 5-HT neurite
density. We conclude that these organotypic slice co-cultures
can be used to study 5-HT outgrowth and the effect of 5-HT
pharmacological compounds on this outgrowth in vitro.Fig. 1 – Overview of the culturing method. The DRN and
hippocampal slice were positioned close to each other to
allow 5-HT neurites to grow into the hippocampal slice. After
culturing for 7 days, the slices flatten and several cells (e.g.
macrophages) migrate away from the slices. Scale bar:
500 μm.2. Results
2.1. Development and outgrowth of 5-HT neurons in
organotypic slice co-cultures
To study the outgrowth of 5-HT neurites ex vivo, we used
organotypic slice co-cultures of the DRN and a hippocampalslice. We positioned the slices close to each other to allow 5-
HT neurites to grow into the hippocampal slice. Within 7 days
of culturing the slices flattened out and several non-neuronal
cells migrated away from the slices (Fig. 1). We performed
immunocytochemistry for 5-HT to investigate whether 5-HT
neurons survived in the slices. This showed that in several
DRN slices 5-HT neurons were present, which resembled the
topology of the 5-HT neurons in the DRN in vivo (Fig. 2A).
However, there were also DRN slices that contained only few
5-HT neurons, possibly resulting from a variation in the
dissection of the DRN slice. A Z-stack of 5-HT cell somata
showed that these cells have several primary neurites that
contain numerous varicosities (Fig. 2B). In the growth cones of
5-HT neurites, 5-HT was also detected (Fig. 2C). Next, we
focused on the expression of Tph and SERT, two markers for
the 5-HT system. In 5-HT-immunopositive cell bodies and in
the 5-HT neurites and varicosities, Tph was also expressed
(Figs. 2D and E). We found that all the 5-HT neurites were
positive for SERT labeling, with the highest level of SERT
staining on the soma and in the 5-HT varicosities (Figs. 2F and
G). Moreover, SERT was also expressed in a punctuate pattern
in the 5-HT growth cones (Fig. 2H). In vivo, 5-HT is released
from varicosities in 5-HT axons and dendrites and 5-HT
release is predominantly paracrine (Bunin and Wightman,
1999). In the slices, the 5-HT neurites contained several round
and fusiform shaped varicosities (Figs. 3A and B). Immunocy-
tochemistry revealed that in these varicosities, the calcium
sensor synaptotagmin and the active zone marker Bassoon
are present, suggesting that the varicosities are presynaptic
sites where calcium-dependent 5-HT release occurs (Figs. 3C
and D; Perin et al., 1991; tom Dieck et al., 1998). This showed
Fig. 2 – 5-HT neurons survive in the slice and grow out several 5-HT neurites. (A) A DRN slice cultured for 7 dayswhich is stained
for 5-HT shows that several 5-HT cells are present in the slice. Note the presence of the lateral wings of the DRN (arrows) and the
group of 5-HT neurons in the ventral part of the DRN (arrowhead). (B) A Z-stack of two cells shows that the cells project several
neurites that are 5-HT positive. (C) The growth cones also contain 5-HT, both in the core (arrowhead) and in the filopodia
(arrows). (D, E) Staining for the rate limiting enzymeTph shows that Tph is present both in the cell bodies and in the varicosities
in the neurites. (F, G) The othermarker for the 5-HT system, SERT, is present in 5-HT cell bodies and 5-HTneurites. (G) Moreover,
there is also a punctuate SERT staining in 5-HT growth cones, both in the core (arrowhead) and in the filopodia (arrows). Scale
bars: 200 μm in A, 50 μm in B and D, 20 μm in F and G, 5 μm in C and E and 2 μm in H.
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5-HT neurons survive and grow out neurites that contain 5-HT
varicosities with immunoreactivity for all tested components
of the 5-HT release machinery.
2.2. Dense ingrowth of 5-HT neurites into hippocampal
slices
To study the outgrowth, we fixed slice cultures at different
time points and quantified the 5-HT outgrowth. To this end,
the images were converted to binary images and the 5-HT
neurite density in the slices was quantified (Figs. 4A–C). We
quantified the 5-HT neurite density as the area in the slice
occupied by 5-HT neurites compared to the total area of the
slice. Immunocytochemistry for 5-HT on hippocampal slices
cultured without the DRN for 7 days revealed that there were
no 5-HT neurites present (Fig. 4E). Thus, 5-HT neurites
observed in the hippocampal slice in co-cultures are the result
of re-growth of 5-HT neurites from the DRN slice. In co-
cultures fixed at DIV4, we observed that the DRN slice already
contained several 5-HT neurites, and the first 5-HT neurites
started to grow into the hippocampal slice (Figs. 4F and I). At
DIV7, also the hippocampal slice contained several 5-HTneurites (Figs. 4G and J). Quantification of the 5-HT neurite
density in the slices at DIV14 and DIV21 revealed that this was
not significantly different fromDIV7 (Figs. 4D and H; DIV7 DRN
8.42%±0.8%, HIP 6.31%±0.84%, n=16; DIV14 DRN 9.49%±
1.42%, HIP 5.12%±0.9%, n=12; DIV21 DRN 9.26%±1.16%, HIP
6.61%±1.43%, n=4). We investigated whether there is regional
variation in the 5-HT neurite distribution in the hippocampus.
At DIV4, the first 5-HT neurites that start growing into the
hippocampal slice do not appear to display a preference for a
certain region (Fig. 4K). At DIV7, 5-HT neurites have grown in a
uniform distribution into the hippocampus, and there are no
regions that contain a higher density of 5-HT neurites than
other regions (Fig. 4L). Thus, the initial outgrowth of the 5-HT
neurites occurs in the first 7 days, after which the network
stabilizes, and the homogenous distribution suggests that 5-
HT neurites do not have any preferential target region within
the hippocampal slice in vitro.
2.3. The effect of 5-HT pharmacological compounds on the
outgrowth of 5-HT projections
Finally, we studied whether this culture model system can
be used to study the effect of chronic application of 5-HT
Fig. 3 – 5-HT neurites contain several varicosities which are positive for presynaptic markers. (A) A Z-stack in the hippocampal
slice shows that several thin, highly branching 5-HT neurites have grown into the slice. (B) A blow-up of the red box in A
shows that these neurites contain several varicosities. (C, D) These varicosities are positive for the protein involved in
calcium-dependent secretion, synaptotagmin (Syt) and for the active zone marker Bassoon. Scale bars: 50 μm in A, 10 μm in B
and D and 2 μm in C.
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neurites. There are several 5-HT receptors that are expressed
in both the DRN and the hippocampus. These include the 5-
HT1A receptor, the 5-HT2 receptor and the 5-HT7 receptor
(Bickmeyer et al., 2002; Clemett et al., 2000; Garcia-Alcocer et
al., 2006; Gustafson et al., 1996; Xu and Pandey, 2000). Since it
has been shown before, also on non-5-HT cells, that (chronic)
activation of a 5-HT1A or 5-HT2 receptor or blockade of the
SERT can affect (5-HT) outgrowth or synaptogenesis, we
decided to use a 5-HT1A receptor agonist (8-OH-DPAT), a 5-
HT2 receptor agonist (DOI hydrochloride) and the SERT
inhibitor fluoxetine (Fricker et al., 2005; Kondoh et al., 2004;
Wilson et al., 1998; Zhou et al., 2006). We chronically applied
the pharmacological compounds in 10 μM concentrations
during the first 7 days of outgrowth.
First of all, we studied the effect of chronic blockade of the
SERT by fluoxetine. Fluoxetine did not affect 5-HT neurite
density (fluoxetine: DRN, 8.44±0.72; HIP, 6.12±1.12; n=10)
compared to control condition (Figs. 5A, B, E, F). Subsequent-
ly, we tested the effect of chronically activating the 5-HT1A
and 5-HT2 receptor, two receptors that are present on 5-HT
neurons. Moreover, it has been shown previously that
activation of these receptors can affect outgrowth of Purkinje
cells (Kondoh et al., 2004). First we investigated the effect ofthe 5-HT1A receptor agonist 8-OH-DPAT. Activation of the
autoreceptor by 5-HT or an agonist results in a reduction in
5-HT release (Quick, 2003). However, 8-OH-DPAT did not
affect 5-HT neurite density (DRN, 10.67%±0.79%; HIP, 7.21%±
0.9%; n=9; Figs. 5C, E, F).
Next, we investigated the effect of chronic 5-HT2 receptor
activation. Activation of the 5-HT2 receptor results in an
increased protein kinase C activity and release of calcium from
internal stores. We chronically activated the 5-HT2 receptor
by applying the 5-HT2 receptor agonist DOI hydrochloride.
Chronic application of the 5-HT2 receptor agonist DOI hydro-
chloride resulted in a significantly decreased 5-HT neurite
density (Figs. 5D–F; DRN, 2.94%±1.01%; HIP, 2.29%±1.05%;
n=5). To exclude the possibility that pharmacological treat-
ment affected the survival of 5-HT neurons, we counted the
number of 5-HT cells per group. This showed that treatment
with fluoxetine, 8-OH-DPAT or DOI hydrochloride did not
affect the number of 5-HT neurons in the slices (data not
shown). Hence, changes in viability of 5-HT neurons cannot
explain the effect of DOI hydrochloride. We conclude that
these organotypic slice co-cultures can be used to study the 5-
HT outgrowth and ingrowth into a target area in vitro and that
chronic activation of the 5-HT2 receptor results in a decreased
5-HT neurite density.
Fig. 4 – Dense ingrowth of 5-HT neurites into hippocampal slices within 7 days of culturing. An original image of a hippocampal
slice co-cultured with a DRN slice shows that there is abundant ingrowth of 5-HT neurites, but there is also a lot of red
background staining. (B)When this image is converted to a binary image using the steps described in Experimental procedures,
the 5-HT neurites are positively labeled (black), whereas the background is removed (white). (C) A blow-up of part of the binary
image shows that all 5-HT neurites are detected, and the red background is removed. (D) Quantification of the 5-HT neurite
density (Y-axis) in the DRN and hippocampal slices at DIV 7, 14 and 21. (E) A hippocampal slice cultured without the DRN
contains only background staining and no 5-HT neurites. (F, I) Maximal 5-HT ingrowth of the slices is reached in the first 7 days
of culturing. At DIV4, the DRN slice already contains several 5-HT neurites, and the first 5-HT neurites start to grow into the
hippocampal slice. (G, J) At DIV7, both the DRN and hippocampal slice contain abundant 5-HT neurites. (H) At DIV21, the 5-HT
neurite density in the slices has not changed. (K, L) No regional variation in 5-HT neurite density in the hippocampal slice at
DIV4 (K) and DIV7 (L). Panels I and J are a blow-up of the black box in panels F andG, respectively. Panels K and L are blow-ups of
the hippocampal slices in panels F and G, respectively. Scale bars: 500 μm in A, B, E, F, G, H, I, J, K and L, 20 μm in C.
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Fig. 5 – Chronic application of a 5-HT2 agonist reduces 5-HT neurite density in the slices. (A) In control condition, after 7 days of
culturing several 5-HT neurites have grown into the slices. (B) Chronic blockade of the SERT with the SERT inhibitor fluoxetine
did not affect 5-HT neurite density in the slices. (C) Chronic activation of the 5-HT1A receptor with 8-OH-DPAT also did not affect
5-HT neurite density in the slices. (D) However, chronic activation of the 5-HT2 receptor with DOI significantly reduced 5-HT
neurite density both in the DRN and hippocampal slice. (E, F) Quantification of 5-HT neurite density in the DRN slice and
hippocampal slice, respectively. Scale bar: 500 μm. *p<0.05, **p<0.01, ***p<0.001.
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3.1. An organotypic co-culture model system to study 5-HT
outgrowth ex vivo
We used organotypic slice co-cultures to study the outgrowth
of the 5-HT system ex vivo. Neurite projections of 5-HT
neurons grew into the slices, and at 7 days a dense network
had formed with many serotonergic boutons that had accu-
mulatedpresynapticmarkers. The regional differences in 5-HT
innervation observed in the hippocampus in vivo were not
reproduced ex vivo, and it has been observed that fewer
synapses form in slices than in vivo (see discussion in Papp et
al., 1995). However, also in vivo themajority of the 5-HT release
sites (70–80%;OleskevichandDescarries, 1990) arenot classical
synapses, i.e., with a juxtaposed postsynaptic specialization.
Hence, the in vivo connectivity of the 5-HT system appears to
depend largely on non-synaptic release. Therefore, despite
some discrepancies compared to the in vivo situation, the slice
co-culture system is an excellent, reduced model to unravel
the basic principles that orchestrate 5-HT neurite outgrowth
and connectivity. Such a reduced system is a valuable
supplementation of in vivo studies, which are often compli-cated by the exceptionally complex and dynamic connectivity
of the 5-HT system, with for instance large fluctuations in
innervation over the course of a few days (transient hyper-
innervation, see Fujimiya et al., 1986; D'Amato et al., 1987).
3.2. Chronic activation of the 5-HT2 receptor decreased
5-HT neurite density
We found that chronic application of a 5-HT2 agonist
decreased the neurite density of 5-HT neurites. Since DOI
hydrochloride treatment did not affect 5-HT neuron survival,
5-HT-mediated cytotoxicity cannot explain the decrease in 5-
HT neurite density. Hence, the decreased neurite density
appears to be the result of a specific effect of the activation of
the 5-HT2 receptor on the neurites (decreased outgrowth/
increased pruning). In contrast, chronic activation of the 5-
HT1A receptor did not mimic the effects of 5-HT, although the
5-HT1A receptor has often been implicated in shaping 5-HT
connectivity (Gross et al., 2000, 2002). Activation of somato-
dendritic 5-HT1A receptors results in hyperpolarization and a
decrease in 5-HT release (Quick, 2003). However, chronic
activation results in rapid desensitization (Assie et al., 2006),
whichmay explain why we do not observe an effect of chronic
5-HT1A receptor activation. On the other hand, 5-HT2 receptor
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tein kinase C (Tamir et al., 1992). This suggests that (chronic)
activation of the 5-HT2 receptor affects outgrowth since
elevation of calcium levels in growth cones reduces outgrowth
(Gomez and Spitzer, 1999). Since DOI hydrochloride has
comparable affinity for the 5-HT2A and 5-HT2C receptor
subtype, based on these data we cannot conclude which of
the two subtypes is involved in the effect of DOI hydrochloride.
However, although the 5-HT2A receptor is widely expressed
throughout the brain, the receptor seems not to be expressed
in the DRN (Xu and Pandey, 2000). In contrast, the 5-HT2C
receptor is present in the DRN (Clemett et al., 2000; Serrats et
al., 2005). Moreover, it has been shown previously that
activation of the 5-HT2C receptor in the DRN results in a
reduction in 5-HT neuron firing (Boothman et al., 2006).
Therefore, based on the anatomical distribution, we speculate
that the effect of DOI hydrochloride is predominantly medi-
ated via the 5-HT2C receptor. Fluoxetine did not decrease 5-HT
neurite density. It could be expected that fluoxetine applica-
tion mimics a 5-HT1A receptor agonist, i.e., SERT blockade
results in an increase in extracellular 5-HT that could activate
5-HT1A autoreceptors. However, possibly upon application of
fluoxetine extracellular 5-HT is rapidly diluted in the culture
medium in vitro, and therefore extracellular 5-HT will not
reach high enough concentration levels to mimic the effect of
a 5-HT1A receptor agonist. Also chronic fluoxetine treatment
in vivo failed to produce effects similar to chronic 5-HT
application (Zhou et al., 2006). In fact, chronic fluoxetine
enhanced neurite density in this case (Zhou et al., 2006).
3.3. Conclusions
We have shown here that in DRN, hippocampus organotypic
slice co-cultures 5-HT projections grow into the target slice.
After 4 days of culturing in the DRN slice already several 5-HT
projections were present, and the first 5-HT projections
started to grow into the target slice. Within 7 days of culturing
also the target slice contained several 5-HT neurites. These 5-
HT neurites contained several varicosities, which are presum-
ably sites of 5-HT release since presynaptic markers were
present in these varicosities. Finally, we have shown that this
culture model system can be used to study the effect of
pharmacological manipulations on the outgrowth of 5-HT
neurites and that application of a 5-HT2 agonist results in a
reduction in 5-HT neurite density in the slices.4. Experimental procedures
4.1. Laboratory animals
Wild-type C57BL/6 mouse fetuses were obtained from caesar-
ean section at embryonic day 18 or postnatal day 1. Animals
were housed and bred according to institutional, Dutch andU.S.
governmental guidelines.
4.2. Pharmacological compounds and antibodies
Mouse monoclonal anti-tryptophan hydroxylase (Tph) anti-
body, which detects both Tph1 and Tph2, was obtainedfrom Sigma-Aldrich and used in a 1:1000 dilution. Rabbit
anti-5-HT polyclonal and mouse anti-SERT monoclonal
antibodies were obtained from Immunostar/Diasorin and
used in a 1:1000 dilution. Bassoon and synaptotagmin
monoclonal antibodies were used in a 1:500 and 1:1000
dilutions, respectively, and obtained from Stressgen. As
secondary antibodies, Alexa593-conjugated goat anti-rabbit
and Alexa488-conjugated goat anti-mouse were used in a
1:1000 dilution (Molecular probes). 8-Hydroxy-2-(di-n-propy-
lamino)tetraline (8-OH-DPAT) and (+-)-2,5-dimethoxy-4-
iodoamphetamine hydrochloride (DOI hydrochloride) were
obtained from Sigma-Aldrich. Fluoxetine was obtained from
Tocris.
4.3. Organotypic slice co-cultures
Organotypic slice cultures were made as follows. After
decapitation of the fetuses, the heads were immediately
transferred to ice-cold dissection Gey's balanced salt solution
(dGBSS, Invitrogen, supplemented with 0.65 g/l glucose and
200 μM kynurenic acid). For isolation of a DRN slice, the brains
were dissected in dGBSS and the midbrain cut into 400 μm
thick slices using a McIlwain tissue chopper (Mickle Engineer-
ing, Gomshall, UK). Individual slices were separated in dGBSS
and the hindbrain slice containing the rostral DRN was
identified by visual inspection. The DRN was dissected out
using a dissection knife. The entire hippocampus was
dissected out of the brain and individual slices (400 μm) were
sagittally cut perpendicular to the hippocampus' longitudinal
axis. The hippocampal and DRN slices were allowed to
recuperate in dGBSS at 4 °C for 60 min. A hippocampal and
DRN slice were cultured in close proximity on a poly-D-lysine
coated 12×24 glass coverslip (O. Kindler GmbH & Co.
Mikroskopische Gläser, Freiburg, Germany) in a plasma clot
(chicken plasma; Cocalico Biologicals Inc. Reamstown, U.S.),
which was coagulated with thrombin (Merck, Darmstadt,
Germany). Culturing medium consisted of 50% BME Hanks,
25% Hanks balanced salt solution and 25% horse serum
supplemented with 1.3 g/l glucose and 200 μM glutamine.
For culturing, 700 μl of culturing medium was added to the
slices in a Nunc flat-bottomed tube. The slices were incubated
in a roller drum at 36 °C. After the first week, medium was
changed twice a week.
4.4. Pharmacological treatments
All pharmacological compounds were dissolved in ddH2O,
filter sterilized and aliquots stored at −80 °C. After 1 day in
vitro (DIV), 10 μM of the pharmacological compound was
added to the slices. Every day, a new aliquot of pharmacolog-
ical compound was added to the slices. In control slices, only
vehicle was added (sterile ddH2O). At DIV7, the slices were
fixed, processed and analyzed as described below.
4.5. Immunocytochemistry
Slices were fixed for 20 min in 4% paraformaldehyde
dissolved in phosphate-buffered saline. After fixation, the
slices were washed three times for 5 min in PBS, and
nonspecific binding was blocked by incubating the slices in
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for 2 h. The slices were incubated overnight with the
primary antibodies diluted in phosphate-buffered saline
containing 0.1% Triton X-100 supplemented with 2% normal
goat serum at 4 °C. After incubation in the primary
antibodies, the slices were washed three times for 2 h in
phosphate-buffered saline on a shaking platform. The
secondary antibodies were diluted in phosphate-buffered
saline supplemented with 2% normal goat serum and
incubated for 1 h. After incubation in the secondary
antibodies, the slices were washed again three times for 2 h in
phosphate-buffered saline and mounted in Dabco-Mowiol
(Sigma) on glass coverslips. All reactions were carried out at
room temperature unless otherwise stated. No labeling was
observed when omitting the primary antibodies.
4.6. Confocal analysis
Confocal analysis of the slices was performed on a LSM 510
microscope (Carl Zeiss b.v. Weesp, the Netherlands) and a
63× Plan-Neofluar lens (Numerical aperture 1.4, Carl Zeiss).
To excite the 488 antibody, a HeNe1 laser was used and for
excitation of the 593 antibody a HeNe2 laser was used. For
analysis of the 5-HT neuron morphology and the 5-HT
neurites, Z-stacks of 1 μm were made. Images were analyzed
and further processed in Zeiss CLSM software.
4.7. Histological quantification of 5-HT neurite density
Quantification of 5-HT-immunopositive neurites and cells
was performed using an MCID Elite imaging system (Imaging
Research Inc., Ontario, Canada). Images of the immunos-
tained co-cultures were digitized using an objective magni-
fication of 20× on a Leica DM/RBE photo-microscope with a
Sony (DXC-950P, 640×512 pixels) camera using epifluores-
cence microscopy. The 5-HT-immunopositive neurites were
segregated from background using several point operators
and spatial filters combined in an algorithm designed to
detect local changes in relative optical density. Briefly,
images underwent histogram equalization and smoothing
(low-pass filter, kernel size 7×7). The unfiltered image was
subtracted from the smoothed image, followed by a series of
steps to optimize the processed image and make it a suitable
measuring template for detecting objects the size and shape
of 5-HT neurites or cell bodies. This algorithm was preferred
over relative optical density thresholding since it does not
involve an observer-dependent operation. Finally, a line was
manually drawn around the DRN or hippocampal slice, and
the number of positive pixels (i.e., pixels representing 5-HT
neurites) compared to the total number of pixels was
calculated. The number of 5-HT neurons was counted
manually in the slices.
4.8. Data analysis
In order to analyze differences in neurite density between
different pharmacological treatments, ANOVA was used with
the Bonferroni test for post hoc analysis. Data shown aremean
values±standard errors of mean. Significance levels were set
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